Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-002862
Filing Date
2024-05-15
Accepted
2024-05-14 18:58:59
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q qron_10q.htm   iXBRL 10-Q 842041
2 CERTIFICATION qron_ex31.htm EX-31 10027
3 CERTIFICATION qron_ex32.htm EX-32 3946
  Complete submission text file 0001477932-24-002862.txt   4968279

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qron-20240331.xsd EX-101.SCH 55217
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qron-20240331_lab.xml EX-101.LAB 271847
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qron-20240331_cal.xml EX-101.CAL 36782
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qron-20240331_pre.xml EX-101.PRE 250807
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qron-20240331_def.xml EX-101.DEF 166047
69 EXTRACTED XBRL INSTANCE DOCUMENT qron_10q_htm.xml XML 971707
Mailing Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101
Business Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101 212-945-2080
Qrons Inc. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55800 | Film No.: 24946447
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)